Baroda BNP Paribas Value Fund
Direct · GrowthAI Summary
Baroda BNP Paribas Value Fund has consistently outperformed its benchmark (NIFTY50 VALUE 20) across all periods, with positive alpha of 7.26% over 1Y and 5.03% over 3Y, and the fund's 3Y CAGR of 11.07% beating the benchmark's 6.01%. However, its SIP XIRR of 8.78% (1Y) and 3.78% (3Y) trails the category average SIP XIRR of 17.71% and 17.43% respectively, indicating significant underperformance versus value fund peers on SIP returns. Lump-sum rolling returns are healthier, with 3Y rolling mean of 11.28%.
The fund exhibits strong downside protection with a downside capture of 79.57% (1Y) to 85.42% (3Y) versus upside capture around 90-93%, meaning it falls less than the benchmark in weak markets. Only one drawdown event exceeding 10% occurred, with a maximum drawdown of just -0.20% over 154 days, though recovery has not yet been recorded. Calmar ratios of 0.52 (1Y) and 0.57 (3Y) suggest moderate risk-adjusted returns, and beta below 0.93 across periods confirms lower volatility than the benchmark.
The 48-stock portfolio is well diversified, with the top holding Reliance Industries at just 6.84% and the top 10 holdings totaling roughly 41.4% of NAV. Banks (17.1%) and Pharmaceuticals (13.0%) are the largest sector exposures, followed by Electrical Equipment (9.0%), IT (7.8%), and Petroleum (6.8%). The mix of large-cap financials, pharma, capital goods names like BHEL and GE Vernova T&D, and Infosys reflects a classic value-oriented, broadly diversified approach.
While the fund beats its benchmark consistently, it lags the value category average SIP XIRR by a wide margin — 3.78% versus 17.43% over 3Y and 8.78% versus 17.71% over 1Y — placing it in the lower tier of peers on SIP returns. Calendar year returns show volatility in consistency, ranging from 22.43% in 2023 to -2.19% in 2026. Its strength lies in benchmark-relative alpha rather than category-relative performance.
This fund suits conservative value investors seeking benchmark outperformance with lower downside capture, rather than those chasing top-of-category SIP returns. A long-term horizon of 5-7+ years is appropriate given the value style's cyclical performance, and investors should tolerate periods of significant category underperformance. It can serve as a diversifier within a broader equity portfolio due to its defensive capture profile.
- Positive alpha across all measured periods, from 7.26% over 1Y to 2.99% over 5Y versus the NIFTY50 VALUE 20 benchmark
- Strong downside protection with downside capture of 79.57% (1Y) and only one drawdown event exceeding 10%
- Well-diversified 48-stock portfolio with no single holding above 6.84% of NAV
- Significant SIP XIRR underperformance versus category averages — 3.78% vs 17.43% over 3Y and 8.78% vs 17.71% over 1Y
- Maximum drawdown of -0.20% has not yet recovered after 154 days, and calendar year returns show inconsistency (22.43% in 2023 to -2.19% in 2026)
Generated on 10-09-2026, 3:05 AM. Verify before investing.
Gives more importance to longer time periods (10Y, 20Y) than shorter ones (1Y, 3Y). This balances out recent outperformance and gives a more realistic picture of what long-term returns might look like.
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
If you invested ₹1,00,000 every month via SIP, here's how this fund has historically performed across different time horizons.
| Duration | Invested | Median Value | XIRR | Min XIRR | Max XIRR |
|---|---|---|---|---|---|
| 1 Year | ₹12.00 L | ₹12.15 L | 8.8% | -24.7% | 58.7% |
| 3 Years | ₹36.00 L | ₹38.01 L | 3.8% | 1.7% | 6.2% |
SIP returns vs benchmark & category
Annualised SIP return (XIRR) over each rolling horizon — like-for-like, not lump-sum.
| Duration | Fund SIP XIRR | NIFTY50 VALUE 20 | Category avg | Fund edge |
|---|---|---|---|---|
| 1 Year | 8.8% | 15.2% | 17.7% | -6.5% |
| 3 Years | 3.8% | 13.1% | 17.4% | -9.4% |
| Duration | Mean | Median | Min | Max | Sharpe | Sortino | % Positive | Cat. Mean | Cat. Median |
|---|---|---|---|---|---|---|---|---|---|
| 1 Year | 10.2% | 2.7% | -11.5% | 48.8% | 0.20 | 0.52 | 64% | — | — |
| 3 Years | 11.3% | 11.2% | 9.8% | 12.8% | 6.25 | — | 100% | — | — |
Calmar Ratio by Duration
Compared against NIFTY50 VALUE 20
| Duration | Alpha | Beta | Upside Capture | Downside Capture | Fund CAGR | Bench CAGR |
|---|---|---|---|---|---|---|
| 1 Year | +7.26 | 0.88 | 90.5% | 79.6% | 3.1% | -5.5% |
| 3 Years | +5.03 | 0.93 | 93.1% | 85.4% | 11.1% | 6.0% |
| 5 Years | +2.99 | 0.90 | 90.5% | 83.0% | 7.5% | 4.3% |
| 7 Years | +1.91 | 0.90 | 90.5% | 83.0% | 5.3% | 3.0% |
| 10 Years | +1.13 | 0.90 | 90.5% | 83.0% | 3.7% | 2.1% |
| 12 Years | +0.83 | 0.90 | 90.5% | 83.0% | 3.0% | 1.8% |
| 15 Years | +0.53 | 0.90 | 90.5% | 83.0% | 2.4% | 1.4% |
| # | Stock | % of NAV |
|---|---|---|
| 1 | ICICI Bank Limited | 5.27% |
| 2 | Reliance Industries Limited | 5.14% |
| 3 | HDFC Bank Limited | 5.01% |
| 4 | Bharat Heavy Electricals Limited | 4.46% |
| 5 | Larsen & Toubro Limited | 3.87% |
| 6 | GE Vernova T&D India Limited | 3.81% |
| 7 | Divi's Laboratories Limited | 3.81% |
| 8 | Sun Pharmaceutical Industries Limited | 2.70% |
| 9 | Torrent Pharmaceuticals Limited | 2.58% |
| 10 | Infosys Limited | 2.57% |